Quantcast

Latest Nitriles Stories

2011-01-19 08:04:20

(Ivanhoe Newswire) -- A new study shows antidepressants can help reduce hot flashes in menopausal women. In the study, Ellen Freeman, Ph.D., of the University of Pennsylvania School of Medicine, and her colleagues found that women who were either transitioning to menopause or were postmenopausal had less menopausal hot flashes when they used escitalopram (an antidepressant medication) compared to women who received placebo (a dummy medication or treatment). The researchers not only tested to...

2011-01-18 23:09:56

Women who were either in the transition to menopause or postmenopausal experienced a reduction in the frequency and severity of menopausal hot flashes with the use of the antidepressant medication escitalopram, compared to women who received placebo, according to a study in the January 19 issue of JAMA. "Hormonal agents have been the predominant therapy for menopausal hot flashes, but their use decreased substantially following the shifts in risk-benefit ratios that were identified in the...

2010-11-03 04:22:00

NEW YORK, Nov. 3, 2010 /PRNewswire/ -- See video from Lundbeck at: http://www.thenewsmarket.com/CustomLink/CustomLinks.aspx?GUID=0c5e745c-050d-4fe3-8da5-8edbb8bc6db1&bhcp=1&alertid=d0b158ec-152f-49a0-a5a9-4a7a40807750# Danish-based H. Lundbeck A/S, a pharmaceutical company specialized in central nervous system (CNS) disorders, reports third quarter revenue of DKK 3,619 million, an increase of 7% compared to the third quarter results of 2009. Profit from operations (EBIT) was DKK...

2010-10-29 05:45:00

PHILADELPHIA, October 29, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced results from a Phase 2 signal finding study of Vyvanse(R) [lisdexamfetamine dimesylate (or SPD489)] in patients who have had residual symptoms of depression following treatment with LEXAPRO(R) (escitlopram) for Major Depressive Disorder (MDD). Based on these findings, Shire intends to advance discussions with regulators to explore...

2010-07-01 06:00:00

WILMINGTON, Del., July 1 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced a new patient support program for postmenopausal women with hormone receptor-positive early breast cancer who are prescribed ARIMIDEX. The program is designed to provide eligible patients with instant discounts, potentially saving the patient up to $300. (Logo: http://photos.prnewswire.com/prnh/20091027/PH99766LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) When using the...

2010-05-05 07:00:00

CAMBRIDGE, Mass., May 5 /PRNewswire/ -- Sermo (http://www.sermo.com/client), the world's largest online community for physicians, today announced a Sermo Category Report titled Antidepressant Treatment Behaviors. The report surveyed more than 200 primary care physicians and covers a variety of topics including product choice drivers, treatment paths, referring habits, and overall issues in depression management. According to physician respondents, about 30% of their patients suffer from...

a92125d1c35152bd2317fa45d21de032
2010-04-02 11:15:00

The Federal Aviation Administration (FAA) is reversing its longstanding policy prohibiting antidepressant use among pilots, and will allow use of the medication in certain circumstances beginning Monday. According to an April 2 article by Mike Ahlers of CNN, the FAA believes that "pilots with mild to moderate depression will be allowed to fly while taking antidepressants if they can demonstrate they have been satisfactorily treated for at least 12 months." "The new policy will improve safety...

2010-02-01 18:22:22

Patients who received the antidepressant escitalopram following a stroke appeared to recover more of their thinking, learning and memory skills than those taking placebo or participating in problem-solving therapy, according to a report in the February issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Stroke remains a major health care problem and a significant cause of death and disability around the world, according to background information in the article....

2009-10-15 12:05:00

Nortriptyline has been found to cause a ten-fold increase in suicidal thoughts in men when compared to its competitor escitalopram. These findings are published in the open access journal BMC Medicine. The research was carried out by Dr. Nader Perroud from the Institute of Psychiatry, Kings College London, who headed up GENDEP, an international team. Dr Perroud said "Suicidal thoughts and behaviors during antidepressant treatment have prompted warnings by regulatory bodies". He continued "the...

2009-10-02 08:05:00

DETROIT, Oct. 2 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced that, as part of the previously announced settlement of the legal proceedings related to Lexapro® (escitalopram oxalate) tablets, it closed an Asset Purchase Agreement ("APA") transaction with Forest Laboratories, Inc. ("Forest") to acquire several products from Forest's Inwood line of business. The ANDA patent litigation settlement resolves litigation involving...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related